CME INDIA
  • Home
  • CME INDIA Repository
  • CME INDIA Case Study
  • History Today in Medicine
  • Future CMEs
  • About CME INDIA
Select Page
New Drug Semaglutide in T2 Diabetes – What A Physician Must Know?

New Drug Semaglutide in T2 Diabetes – What A Physician Must Know?

by Admin | Jun 18, 2022 | CME INDIA Repository

CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. CME INDIA Discussion (08/04/2022) Dr. Awadhesh K. Singh, DM Endo., Kolkata: On Semaglutide (Rybelsus) (3-7 mg) plus...

Latest Comments

  • dr.prakakash Deshkar on Movement Disorders: What is Hot in Neurology?
  • Prof Dr Pranab Kumar Bhattacharya on History Today in Medicine – Prof. Dr. Asima Chatterjee
  • Anand.V on History Today in Medicine – Prof. Dr. Mammen Chandy
  • Editor on What Physicians Must Know About Non-Pharmacological Management in GDM
  • Dr.Arul MD on What Physicians Must Know About Non-Pharmacological Management in GDM

Latest Posts

  • History Today in Medicine – Dr. John H. Gibbon
  • History Today in Medicine – Dr. Louis Pasteur
  • History Today in Medicine – Dr. Richard Bright
  • History Today in Medicine – Dr. Albert Schweitzer
  • History Today in Medicine – Dr. Thomas Hunt Morgan

Explore CME INDIA

  • About CME INDIA
  • CME INDIA Case Study
  • CME INDIA Downloads
  • CME INDIA Home
  • CME INDIA Repository
  • Future CMEs
  • History Today in Medicine
  • What is CME?
© CME INDIA™ 2023. All content on this site is for academic discussion only. Propelled by Dynamic Cognition.